Marizyme Inc Asset Turnover Ratio (MARZ), as of third quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Marizyme Inc   (MARZ)
 

Marizyme Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2024, Marizyme Inc has not recorded any assets.
Visit Marizyme Inc Balance sheet

Within sector Marizyme Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2024 compared to previous quarter at no. .

Asset Turnover Ratio Definition



MARZ Asset Turnover Ratio (Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
Y / Y Asset Change -42.43 % -44.2 % -43.64 % -43.1 % -41.22 %
Y / Y Revenue Change - - -74.53 % 57.39 % 138.82 %
Asset Turnover Ratio (TTM) - - 0.02 0.02 0.02
MARZ's Total Ranking # # # # #
Seq. Asset Change 3.01 % -4.33 % -2.02 % -40.37 % -0.17 %
Seq. Revenue Change - - -78.18 % -17.06 % -1.73 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2024 Assets at quarter ending Sep 30 2024
Therapeutic Solutions International Inc   0.02 $ 0.085  Millions$ 3.679  Millions
Abcellera Biologics Inc   0.02 $ 32.962  Millions$ 1,439.125  Millions
Cardiff Oncology Inc   0.02 $ 1.615  Millions$ 71.156  Millions
Janux Therapeutics Inc   0.02 $ 13.049  Millions$ 613.956  Millions
Dianthus Therapeutics Inc   0.02 $ 6.811  Millions$ 321.268  Millions
Polomar Health Services, Inc.  0.02 $ 0.055  Millions$ 2.639  Millions
Roivant Sciences Ltd   0.02 $ 125.677  Millions$ 6,809.409  Millions
Absci Corp  0.02 $ 4.207  Millions$ 245.739  Millions
Immunitybio inc   0.02 $ 7.332  Millions$ 428.507  Millions
Aclarion Inc   0.02 $ 0.049  Millions$ 3.116  Millions
Pluri Inc   0.02 $ 0.598  Millions$ 38.231  Millions
Ernexa Therapeutics Inc   0.02 $ 0.598  Millions$ 38.248  Millions
Lexicon Pharmaceuticals Inc   0.02 $ 5.229  Millions$ 335.282  Millions
Catheter Precision Inc   0.01 $ 0.399  Millions$ 27.941  Millions
Celldex Therapeutics inc   0.01 $ 9.976  Millions$ 750.810  Millions
Traws Pharma inc   0.01 $ 0.226  Millions$ 17.119  Millions
Lyra Therapeutics Inc   0.01 $ 1.471  Millions$ 114.366  Millions
Serina Therapeutics Inc   0.01 $ 0.126  Millions$ 10.241  Millions
Aim Immunotech Inc   0.01 $ 0.190  Millions$ 16.218  Millions
Singular Genomics Systems Inc   0.01 $ 2.666  Millions$ 227.781  Millions
Bio Green Med Solution Inc   0.01 $ 0.074  Millions$ 7.135  Millions
Clene Inc   0.01 $ 0.421  Millions$ 42.327  Millions
Insight Molecular Diagnostics Inc   0.01 $ 0.709  Millions$ 72.700  Millions
Vistagen Therapeutics Inc   0.01 $ 0.876  Millions$ 90.197  Millions
Vivosim Labs Inc   0.01 $ 0.103  Millions$ 10.721  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 7.823  Millions
One World Products Inc   0.01 $ 0.003  Millions$ 0.284  Millions
Atrium Therapeutics Inc   0.01 $ 10.117  Millions$ 1,142.056  Millions
Cardio Diagnostics Holdings Inc   0.01 $ 0.036  Millions$ 4.317  Millions
Rafael Holdings Inc  0.01 $ 0.697  Millions$ 98.110  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.